Sunesis Pharmaceuticals Bounces on Results Announcement

Updated on

Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), Amicus Therapeutics, Inc. (NASDAQ:FOLD) and KiOR Inc (OTCMKTS:KIORQ) reached midday making gains this Monday. In the red today are dELiA*s, Inc. (NASDAQ:DLIA), William Lyon Homes (NYSE:WLH) and The Wet Seal, Inc. (NASDAQ:WTSL).

Sign Up For Our Free Newsletter

Sunesis Pharmaceuticals

Sunesis, Amicus Soar on Data Announcements

Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) jumped +51.2% early in the day following the announcement that the company will reveal the results of one of its late-stage drug trials in December. Despite today’s gain, SNSS has declined -48.31% year-to-date.


Amicus Therapeutics, Inc. (NASDAQ:FOLD) got a +15.82% boost off of positive data from one of its product trials. The biopharmaceutical company has had a strong run in recent weeks, its price climbing +17.83% over the past month. Billionaire investor George Soros exited his position in the company in Q3.

The share price of KiOR Inc (OTCMKTS:KIORQ), another ex-Soros holding, surged +15% today, though it’s still down -99.32% year-to-date. The renewable fuels company has fallen -84.25% in the past month alone.

dELiA*s Dips Again

dELiA*s, Inc. (NASDAQ:DLIA) dipped -13.71%, putting its five-day loss at -22.83%. It’s been a tough year for the retailer, the share price of which has fallen -88.86% year-to-date. Despite the stock’s poor performance, Tiger Global has maintained its 3.4-million-share DLIA position since first investing in Q4 2013, and Leon Cooperman initiated a new stake with the purchase of 4.26 million shares in Q3.

William Lyon Homes (NYSE:WLH) plummeted -11.74% early in the day. John Paulson holds 3.32 million WLH shares, a position he initiated in Q2 2013.

The Wet Seal, Inc. (NASDAQ:WTSL) hit midday down -11.64% on the heels of a rating downgrade from analysts at B. Riley. The fashion apparel retailer has had a tough go in 2014, its price falling -91.57% year-to-date.


Leave a Comment